Bio Spec

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Overview

Bio Spec Overview

Ignite Creation Date: 2025-12-25 @ 4:52 AM
Last Modification Date: 2025-12-25 @ 4:52 AM
Retention: SAMPLES_WITH_DNA
Description: 1. The patient's tumor tissue sample before taking Ensatinib
2. The patient's baseline blood sample within the first week before taking Ensantinib
3. Blood samples of patients 4-6 weeks after taking Ensatinib
4. Blood samples within 4 weeks after the patient's disease progression
Section: 1. The patient's tumor tissue sample before taking Ensatinib 2. The patient's baseline blood sample within the first week before taking Ensantinib 3. Blood samples of patients 4-6 weeks after taking Ensatinib 4. Blood samples within 4 weeks after the patient's disease progression